IJMS | Free Full-Text | Free Light Chains κ and λ as New Biomarkers of Selected Diseases
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
Criteria for Presumptive Diagnosis of IgD Multiple Myeloma
Light Chain Myeloma: Symptoms, Treatment, Outlook, More